Web Results

GenSpera Announces Name Change to Inspyr Therapeutics ...

www.businesswire.com/news/home/20160801006092/en/GenSpera-Announces-Change-Inspyr-Therapeutics

Aug 1, 2016 ... GenSpera, Inc. (OTC/QB: GNSZ), a clinical-stage biotechnology company ... shareholder value,” said Peter E. Grebow, Ph.D., Interim Chairman.

GenSpera, Inc. - The Chairman's Blog

www.thechairmansblog.com/genspera/

GenSpera unlocks conventional thinking to conceive, design, and develop curative cancer therapies that are core ... By Craig A. Dionne, Ph.D. | GenSpera, Inc.

GenSpera, Inc. | LinkedIn

www.linkedin.com/company/genspera-inc-

Learn about working at GenSpera, Inc.. Join LinkedIn today for free. See who you know at GenSpera, Inc., leverage your professional network, and get hired.

Engineering a Prostate-Specific Membrane Antigen–Activated ...

stm.sciencemag.org/content/4/140/140ra86

Jun 27, 2012 ... Samuel R. Denmeade,*,; Annastasiah M. Mhaka,; D. Marc Rosen, ... George Wilding,; Michael A. Carducci,; Craig A. Dionne,; Jesper V. Møller,, ...

Tasquinimod is an Allosteric Modulator of HDAC4 Survival Signaling ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3578133/

Nov 13, 2012 ... The active vs. and inactive conformations of HDAC4 were overlaid using the Ca ... Human HIF-Regulated cDNA Plate Array from Signosis Inc (Sunnyvale .... 2% O2, without increasing CO2 and decreasing pH, 60% knock down of HDAC4 ..... Kallberg E, Vogl T, Liberg D, Olsson A, Bjork P, Wilkstrom P, et al.

Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4984914/

Apr 26, 2016 ... ... (ECs) of a variety of solid tumours types (Liu et al, 1997; Chang et al, 1999a, ..... GenSpera, Inc. provided assistance with preparation of this manuscript. ... [ PubMed]; Deniaud A, Sharaf el dein O, Malillier E, Poncet D, Kroemer ... Gill DL, Isaacs JT (1994) The role of calcium, pH, and cell proliferation in the ...

Engineering a Prostate-Specific Membrane Antigen ... - NCBI

www.ncbi.nlm.nih.gov/pmc/articles/PMC3715055/

Purified G202 for animal studies was provided by GenSpera Inc. PSMA fusion ... Inc. Arrays were stained for PSMA according to the method of Milowsky et al. with a .... The role of calcium, pH, and cell proliferation in the programmed (apoptotic) ... Deniaud A, Sharaf el dein O, Malillier E, Poncet D, Kroemer G, Lemaire C, ...

Amino acid containing thapsigargin analogues deplete androgen ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3383025/

May 5, 2009 ... Rabbit polyclonal anti-AR (N-20), Cyclin D1 (H-295), GADD34 (S-20), .... 2A), and completion of the process of cellular fragmentation into Annexin V–positive apoptotic bodies (30, 41, 42). ..... J.T. Isaacs and S.R. Denmeade: financial interest, Genspera, Inc., and .... Singh P, Mhaka AM, Christensen SB, et al.

More Info

GenSpera Announces Management Changes | Business Wire

www.businesswire.com

Mar 22, 2016 ... GenSpera, Inc. (OTC/QB: GNSZ), a biotech company developing a novel ... Peter E. Grebow Ph.D., a GenSpera Director, has been appointed ...

GenSpera, Inc. | Facebook

www.facebook.com

GenSpera, Inc., San Antonio, Texas. 1445 likes · 10 were here. GenSpera, Inc. is a development stage oncology company focused on therapeutics that...

Engineering a Prostate-Specific Membrane Antigen-Activated Tumor ...

content.stockpr.com

Jun 27, 2012 ... Samuel R. Denmeade,1* Annastasiah M. Mhaka,1 D. Marc Rosen,1 ... George Wilding,3 Michael A. Carducci,1 Craig A. Dionne,4 Jesper V. Møller,2,5 Poul Nissen,2,6 ...... Purified G202 for animal studies was provided by GenSpera Inc. ... Milowsky et al. with a PSMA antibody (clone 3E6; Dako) diluted 1:20.